Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group Plc LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 78.50 77.00 80.00 0.00 0.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 159.9 11.0 10.9 7.2 67

The Mission Marketing Share Discussion Threads

Showing 1126 to 1147 of 1450 messages
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
thanks for the posts. I didn't realise BL was such a large % of TMMG. I think the staff numbers can reconcile. i.e. 291 at the end of Dec 16 but closer to 400 (rounded up) today - c.10 months later. I would also assume that they can win the contract and staff up further. i.e. they already have their staff gainfully employed. for my own purposes I am going to take a stab and say an extra 100 employees which will give an extra profit of > £1m - £2m (10k to 20k per employee also with such a prestigious win it should lead to other work won in time. when TMMG announced the 75p LTIP I wrote that I think there was something in the offing that made they confident of such a price being achieved. This sort of contract supports my initial hunch. Further prices rises from here as the recent break through was obviously from insiders. New PI;s will push higher. All IMHO, DYOR + BoL TMG is in my top5 hldgs
thirty fifty twenty
Enormous contract win:- Bray Leino Events landed an "enormous" win as they secured a three-year contract to be the official events agency to the Department for International Trade (DIT). The exhibitions specialists won six sector lots to become the key supplier on the DIT events roster. It means that the firm, which is based in south west England, will deliver around 1,200 high-profile events. The contract is one of the most significant wins in the 40-year history of Bray Leino Group, and reflects recent investment in its events division. Giles Lee, BLG executive chairman, said: "We have built a world-class events team with the capabilities to deliver precisely this kind of international event programme and this win is recognition of their professionalism and quality. "I am proud of what they have achieved and I know they can’t wait to get started." The events will come across a broad range of sectors, from energy and nuclear, through to arts and culture, helping DIT promote British trade around the world over the next three years. Rob Grahamslaw, CEO, Bray Leino Events, said: "It is a privilege to be able to help DIT promote British business interests around the world as its official event supplier, particularly at such an important time. "I’m delighted for our team, they fully deserve this success." BLG has been an official supplier to the Crown Commercial Services for more than 10 years. It has delivered on a range of work for public sector organisations including the Office for National Statistics (ONS), the Royal Mint, the NHS and Innovate UK. The team has delivered successful projects for UK Space Agency, HS2 and UKTI. BLG has also helped clients grow through a range of specialist communication businesses, including conferencing and events, brand development and advertising. Over its 40 year history, the company has also worked on direct response, digital, activation and media. It has offices in Devon, Bristol, London, Chicago, Singapore and Shanghai. The business employs 400 full time specialists and has a turnover of £54m, and is part of The Mission Marketing Group. Http://
jeff h
just about at 2 yr highs, can share price break through?
We are somewhat sceptical about their prospects. Income seekers might be attracted by the 3.9% forecast dividend yield but we generally urge caution when being drawn in by a seemingly attractive dividend from a micro-cap with a somewhat chequered past.
That cracking sound you just heard was the bounce of the 50p ceiling. 3 years ago interim profits were £2.1m - this year they were about 40% higher. Sp just about the same.
dr biotech
Seeing as all the director options kick in only when the share price goes over 75p, any bid would have to be north of that figure... so let's hope a bid does come in!
Please give us a "bid approach" RNS!
value hound
Wtf.. are we finally breaking out...
looks like we might be breaking this long-term resistance. can only hope.
Generally positive comment from Paul Scott on Stockopedia: 'the company reported 6.41p for headline diluted EPS in 2016. So from the above, I imagine we're probably looking at 7.0p+ for 2017. Stockopedia shows broker consensus of 7.3p EPS for 2017, and 8.3p for 2018. I would expect a share like this to trade on a PER of maybe 10-12. So it looks strikingly cheap. Although you do have to factor in the bank debt, and deferred consideration re acquisitions.'
Seems decent enough to me - emphasis on organic growth to counter the IC article a while back.
dr biotech
solid half year report with useful (growing dividend). Just need the share price to push through this long-term range. IMHO.
Results struck me as being very middle of the road. Everything slowly ticking along - no dramas! Surely will re-rate... may have to wait a bit longer. At least for the time being it looks nicer in my portfolio being blue!
Solid interim again. One day this will be re-rated, meanwhile happy to hold for increasing dividend.
interim results this Thursday.
Up to the ceiling at 44, perhaps this is the time.....not holding my great though
dr biotech
Poor reaction to WPP results today?
Like banging your head on a glass ceiling....
dr biotech
approaching usual resistance area. can we break through?
I get that, but if I were them, and I truly trusted my own company, I'd be snapping up every share I could find, or leading a management buyout.... At 6x prospective earnings, wouldn't you?
Chair already holds more than 7% and two other directors are near 1% around £300k. That's substantial in my eyes. I don't know what they earn, but it's likely to be a sizeable sum to them too.
dr biotech
What is the poison pill here? Can't see anything at a very 1st cursory glance. What puts me off badly, before even spending a serious amount of time on this, is that management are not actively buying shares even at this very low apparent valuation. £9k over the last 12 months ish is pretty unconvincing. Heck, if I was inside the business, and I thought the business was quality, and the markets were valuing it at the low side of high-end single digits earnings, I'd be buying at EVERY opportunity, and I'm pretty sure the market would follow. That they aren't is a serious concern.
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
Your Recent History
The Missio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191115 00:48:46